Stocks · Health care · Biological Products, (No Diagnostic Substances)

C4 Therapeutics, Inc.

CCCC Clue Score37
United States Fiscal year ends December CIK 0001662579 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Scott N Boyle
18 Feb 2025
Chief Business Officer
Sold on a plan
669
$3.15
$2.11K
Scott N Boyle
14 Feb 2025
Chief Business Officer
Sold on a plan
490
$3.15
$1.54K

What was left out

Form 4 filings counted 260
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 12
Sales at will 40
Transactions with no price 0
Shares from compensation/vesting 14,138,520
Sales filed before the plan box existed 39
History held since 5 Oct 2020